ETFChannel.com
RVMD Description — Revolution Medicines Inc

Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

Company Name: 
Revolution Medicines Inc
Website: 
www.revmed.com
Sector: 
Biotechnology
Number of ETFs Holding RVMD: 
27
Total Market Value Held by ETFs: 
$303,003,000.12
Total Market Capitalization: 
$2,095,000,000
% of Market Cap. Held by ETFs: 
14.46%
 ETF   RVMD Weight   RVMD Amount 
 XBI   0.98%   $79,299,203         
 VTI   0.00%   $53,180,418         
 VB   0.04%   $45,609,202         
 IWM   0.07%   $40,592,284         
 VBK   0.09%   $26,357,370         
 VXF   0.03%   $24,509,800         
 IWN   0.12%   $15,742,152         
 VHT   0.02%   $4,901,003         
 VTWO   0.07%   $4,363,411         
 IWO   0.02%   $1,963,154         
List of all 27 ETFs holding RVMD »
Quotes delayed 20 minutes

Email EnvelopeFree RVMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.43 out of 4)
49th percentile
(ranked lower than approx. 51% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding RVMD | Revolution Medicines Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.